HOME Top Market Reports Mice Model Market by Type (Inbred, Knockout, Hybrid), Technology (Microinjection, Embryonic stem Cell), Disease (Oncology, Diabetes), Service (Breeding, Quarantine, Genetic testing) & Care Products (Bedding, Feed) - Analysis & Global Forecast to 2020

Mice Model Market by Type (Inbred, Knockout, Hybrid), Technology (Microinjection, Embryonic stem Cell), Disease (Oncology, Diabetes), Service (Breeding, Quarantine, Genetic testing) & Care Products (Bedding, Feed) - Analysis & Global Forecast to 2020

By: marketsandmarkets.com
Publishing Date: January 2016
Report Code: BT 2192

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The mice model market is projected to reach USD 1.49 Billion by 2020 from USD 1.05 Billion in 2015, at a CAGR of 7.1% in the next five years (2015 to 2020). The growth of the overall market can be contributed to ongoing innovations in mice model, continuous support in the form of investments and grants, and personalized medicine fueling the demand for personalized humanized mice model are some of the factors driving the growth of the market. In addition to this, various associations propelling the development of embryonic stem cells and knockout and mutant mice, and increase in R&D activities in pharmaceutical industries are further stimulating the market growth. In the coming years, the mice model market is expected to witness the highest growth rate in the Asia-Pacific region. The high growth in the region can be attributed to less stringent regulations on the use of animal models for research in the region, international alliances for R&D activities in China, growth in regenerative medicine, biomedical, and medical research in Japan, growing presence of global players, development of bioclusters to boost biotechnology industry in India, ongoing biomedical research activities in Australia, and rising pharmaceutical and biotechnology R&D activities.

North America is expected to account for the largest share of the global mice model market. North America’s leadership in the market can be attributed to the revised funding plans by NIH to enhance reproducibility of results, rising demands for monoclonal antibody production, continued and responsible use of animals ensured by animal care organizations, rising preclinical activities by CROs and pharmaceutical companies, and growing stem cell research in Canada.

The report segments the mice model market based on type, technology, disease, and service. The report also includes mice care products market, by type. Mice model market, by type includes inbred, outbred, genetically engineered (Knockout/knockin), conditioned/surgically modified, hybrid/congenic, and spontaneous mutant mice. Inbred mice is expected to account for the largest share of the market in 2015 while genetically engineered are 3expected to register highest growth rate. The highest growth rate of genetically engineered mice can be attributed to high investments in the development of new and innovative knockout models that also increases the application areas for the models

Charles River Laboratories International, Inc. (U.S.), The Jackson Laboratory (U.S.), Taconic Biosciences, Inc. (U.S.), Envigo (U.K.), Covance, Inc. (U.S.), Janvier Labs France), Harbour Antibodies BV (Netherlands), Transgenic, Inc. (Japan), genOway SA (France), and SAGE Labs, Inc. (U.S.) are some of the key players in the mice model market worldwide.

Scope of the Report:

This research report categorizes the global mice model market into the following segments:

Mice Model Market, by Type

  • Inbred Mice
  • Genetically Modified Mice (Knockout/ Knock-in)
  • Conditioned/Surgically Modified Mice
  • Hybrid/Congenic Mice
  • Outbred Mice
  • Spontaneous Mutant Mice

Mice Model Market, by Technology

  • Microinjection
  • Embryonic Stem Cell Injection
  • Nuclear Transferase
  • Other Technologies (Genetically modified sperm-mediated gene transfer, Virus/Vector-mediated gene transfer, Liposome-mediated DNA & Electroporation of DNA, Biolistics, and CRISPR/Cas9, TALENs & ZFN)

Mice Model Market, by Disease

  • Oncology Mice Model
  • Mice model for Immunology and Inflammation Studies
  • Mice model for Diabetes Studies
  • Mice model for Cardiovascular Studies
  • Mice model for Central Nervous System Studies
  • Mice model for Metabolism and Regulation Studies
  • Mice model for Other Disease Studies (Rare Diseases and Renal Disorders)

Mice Model Market, by Service

  • Breeding Services
  • Cryopreservation
  • Quarantine
  • Rederivation
  • Genetic Testing
  • Model in licensing
  • Other Services (Surgical, Line Rescue, In Vivo Pharmacology Services )

Mice Care Products Market, by Type

  • Bedding
  • Cages
  • Feed
  • Other products (Gnotobiotic Equipment, Water Systems, Accessories)

*Note: Accessories include washing systems, logistics, water purification systems, and sound absorption panels.

Mice Model Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Rest of Europe (RoE)
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of APAC
  • Rest of the World (RoW)

Stakeholders of the Mice Model Market 

  • Mice Model and Services Companies
  • Mice Model and Services Distributors
  • Animal Care Products Manufacturers and Suppliers
  • Out–licensing Life Sciences Companies (Pharmaceutical/Biopharmaceutical/Biotechnology)
  • In–licensing Life Sciences Companies (Pharmaceutical/Biopharmaceutical/Biotechnology)
  • Clinical Research Organizations (CROs)
  • Academic Institutes
  • Government and Private Research Institutes
  • Medical Research Centers
  • Public and Private Animal Health Agencies
  • Animal Care Associations
  • Business Consultancies
  • Venture Capitalists

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization option is available for the report:

Portfolio Assessment

Product Matrix, which gives a detailed comparison of the product portfolios of the top three companies in the market.

Table of Contents

1 Introduction (Page No. - 21)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 25)
    2.1 Research Methodology Steps
    2.2 Secondary and Primary Research Methodology
           2.2.1 Secondary Research
                    2.2.1.1 Key Data From Secondary Sources
           2.2.2 Primary Research
                    2.2.2.1 Key Industry Insights
                    2.2.2.2 Key Data From Primary Sources
                    2.2.2.3 Key Insights From Primary Sources
    2.3 Market Size Estimation Methodology
    2.4 Market Forecast Methodology
    2.5 Market Data Validation and Triangulation
    2.6 Assumptions

3 Executive Summary (Page No. - 34)
    3.1 Introduction
    3.2 Current Scenario
    3.3 Future Outlook
    3.4 Conclusion

4 Premium Insights (Page No. - 39)
    4.1 Global Mice Model Market
    4.2 Geographic Analysis: Mice Care Products Market, By Type
    4.3 Market, By Technology (2015 vs 2020)

5 Market Overview (Page No. - 43)
    5.1 Introduction
    5.2 Market Segmentation
    5.3 Market Dynamics
           5.3.1 Drivers
                    5.3.1.1 Ongoing Innovations in Mice Model
                               5.3.1.1.1 Mice Model for Immune Diseases
                               5.3.1.1.2 Mice Model for Cancer
                               5.3.1.1.3 Mice Model for Rare Diseases
                    5.3.1.2 Personalized Medicine to Fuel the Demand for Personalized Humanized Mice Model
                    5.3.1.3 Continuous Support in the Form of Grants and Investments
                    5.3.1.4 Increase in R&D Activities of Pharmaceutical Industries
                    5.3.1.5 Increasing Focus of Associations on the Development of Embryonic Stem (ES) Cells as Well as Knockout and Mutant Mice
                               5.3.1.5.1 International Mouse Phenotyping Consortium (IMPC)
                               5.3.1.5.2 International Knockout Mouse Consortium (IKMC)
           5.3.2 Restraints
                    5.3.2.1 Increased Usage of Rat Models
                    5.3.2.2 Advances in Zebrafish Model Development
                    5.3.2.3 Increased Benefits From Cryopreservation
                    5.3.2.4 Regulations and Laws for Ethical Use of Animals in Research
                               5.3.2.4.1 The Animal Welfare Act (Awa)
                               5.3.2.4.2 Public Health Service Policy (PHS)On Humane Care and Use of Laboratory Animals
                    5.3.2.5 Alternative Methods to Animal Testing
           5.3.3 Opportunities
                    5.3.3.1 Rising Demand of Humanized Mice Model
                    5.3.3.2 Increase in Monoclonal Antibody Production
           5.3.4 Challenge
                    5.3.4.1 Need for Improved Mice Model

6 Mice Model Market, By Type (Page No. - 55)
    6.1 Introduction
    6.2 Inbred Mice
    6.3 Outbred Mice
    6.4 Genetically Engineered (Knockout & Knockin) Mice
    6.5 Hybrid/Congenic Mice
    6.6 Conditioned/Surgically Modified Mice
    6.7 Spontaneous Mutant Mice

7 Mice Model Market, By Technology (Page No. - 65)
    7.1 Introduction
    7.2 Microinjection
    7.3 Embryonic Stem Cell Injection
    7.4 Nuclear Transferase
    7.5 Other Technologies
           7.5.1 Genetically Modified Sperm-Mediated Gene Transfer
           7.5.2 Virus/Vector-Mediated Gene Transfer
           7.5.3 Liposome-Mediated Dna and Electroporation of Dna
           7.5.4 Biolistics
           7.5.5 Crispr/Cas9, Talens, and Zfns

8 Mice Model Market, By Service (Page No. - 74)
    8.1 Introduction
    8.2 Breeding Services
    8.3 Cryopreservation Services
    8.4 Quarantine Services
    8.5 Rederivation Services
    8.6 Model In-Licensing Services
    8.7 Genetic Testing Services
    8.8 Other Services

9 Mice Model Market, By Disease (Page No. - 85)
    9.1 Introduction
    9.2 Oncology Mice Model 
           9.2.1 Continuous Grants/Funds to Support Cancer Research Studies
           9.2.2 Agreements/Collaborations to Strengthen Cancer Research
           9.2.3 Introduction of New Mice Model for Specific Cancers
           9.2.4 Expansions to Support Cancer Research Facilities
    9.3 Mice Model for Immunology and Inflammation Studies
    9.4 Mice Model for Diabetes Studies
    9.5 Mice Model for Cardiovascular Studies
    9.6 Mice Model for Central Nervous System (CNS) Studies
    9.7 Mice Model for Metabolism and Regulation Studies
    9.8 Mice Model for Other Disease Studies

10 Mice Care Products Market, By Type (Page No. - 99)
     10.1 Introduction
     10.2 Cages
     10.3 Feed
     10.4 Bedding
     10.5 Others

11 Mice Model Market, By Region (Page No. - 106)
     11.1 Introduction
     11.2 North America
             11.2.1 U.S.
                        11.2.1.1 Revised Funding Plans By the Nih to Enhance Reproducibility of Results
                        11.2.1.2 Growing Biomedical Research in the U.S.
                        11.2.1.3 Monoclonal Antibody Production to Augment the Use of Mice Models
                        11.2.1.4 Continued and Responsible Use of Animals Ensured By Animal Care Organizations
                        11.2.1.5 Development of Biosimilars Boosting the Demand for Preclinical Services
                        11.2.1.6 Preclinical Activities By Cros and Pharmaceutical R&D
                        11.2.1.7 Partnerships Between Cros and Pharmaceutical Companies
             11.2.2 Canada
                        11.2.2.1 Growing Stem Cell Research Activities in Canada
     11.3 Europe
             11.3.1 Germany
                        11.3.1.1 Launch of Pro-Test Deutschland
                        11.3.1.2 Flourishing Biotechnology Industry
             11.3.2 U.K.
                        11.3.2.1 Investors Demand Strong Statistics for Animal Studies in the U.K.
                        11.3.2.2 Increase in Cell Therapy Preclinical Research
             11.3.3 France
                        11.3.3.1 Funding for Rare Disease Projects in France
             11.3.4 Rest of Europe (RoE)
                        11.3.4.1 Improving Biomedical Industry in Russia
                        11.3.4.2 Growth in Biosimilars Market Calls for Increased Preclinical Activities
                        11.3.4.3 Focus on Rare Disease Research Projects
                        11.3.4.4 Events Conducted By Animal Care Associations to Promote the Ethical Use of Mice
                        11.3.4.5 Increase in Tailored Mice Models for Diseases Like Cancer
     11.4 Asia-Pacific
             11.4.1 China
                        11.4.1.1 International Alliances for R&D Activities in China
                        11.4.1.2 Growing Foray of Pharmaceutical and Mice Model Suppliers in China
                        11.4.1.3 Increasing Investments From Government and Private Sectors in China’s Life Sciences Sector
                        11.4.1.4 Initiatives to Reduce Longer Approval Times
                        11.4.1.5 Mandatory Animal Testing for All Pharmaceutical Drugs and Cosmetics in China
                        11.4.1.6 Intellectual Property (IP) Breaches, A Challenge for the Chinese Market
             11.4.2 Japan
                        11.4.2.1 Growth in Biomedical and Medical Research in Japan
                        11.4.2.2 Research Into Regenerative Medicines
             11.4.3 India
                        11.4.3.1 Growing Presence of Global Players
                        11.4.3.2 Development of Bioclusters to Boost India’s Biotechnology Industry
                        11.4.3.3 R&D Activities By Indian Pharmaceutical Companies to Boost Preclinical Research
                        11.4.3.4 Likely Shift of Outsourcing Preclinical Activities From India Towards European Nations
                        11.4.3.5 Limited Infrastructural Facilities in India, A Major Hindrance to the Mice Model Market
                        11.4.3.6 Weak Intellectual Property Environment in India
             11.4.4 Rest of Asia-Pacific (RoAPAC)
                        11.4.4.1 Influx of International Players
                        11.4.4.2 Ongoing Biomedical Research Activities in Australia to Strengthen the Market
                        11.4.4.3 Growth in Translational and Biomedical Research in Singapore
                        11.4.4.4 Increase in Animal Research in Malaysia
                        11.4.4.5 Rising Pharmaceutical and Biotechnology R&D Activities in Korea
     11.5 Rest of World (RoW)
                        11.5.1.1 Pharmaceutical, Biotechnology, and Research Industries in Brazil to Bolster the Market
                        11.5.1.2 Favorable Business Environment for Pharmaceutical and Biotechnology Industries in Saudi Arabia and the Uae

12 Competitive Landscape (Page No. - 172)
     12.1 Overview
     12.2 Market: Market Share Analysis (2014)
             12.2.1 Charles River Laboratories International, Inc.
             12.2.2 the Jackson Laboratory
             12.2.3 Taconic Biosciences, Inc.
             12.2.4 Harlan Laboratories, Inc. (Envigo)
     12.3 Competitive Situation and Trends
             12.3.1 Collaborations, Agreements, Strategic Alliances Partnerships, and Joint Ventures
             12.3.2 Grants & Funds
             12.3.3 Licensing
             12.3.4 New Product Launches
             12.3.5 Expansions
             12.3.6 Patents
             12.3.7 Acquisitions
             12.3.8 Others

13 Company Profiles (Page No. - 190)
     13.1 Introduction
     13.2 Charles River Laboratories International, Inc.
             13.2.1 Business Overview
             13.2.2 Products and Services Offered
             13.2.3 Recent Developments
             13.2.4 MnM View
     13.3 The Jackson Laboratory
             13.3.1 Business Overview
             13.3.2 Products and Services Offered
             13.3.3 Recent Developments
             13.3.4 MnM View
     13.4 Taconic Biosciences, Inc.
             13.4.1 Business Overview
             13.4.2 Products and Services Offered
             13.4.3 Recent Developments
             13.4.4 MnM View
     13.5 Envigo
             13.5.1 Business Overview
             13.5.2 Products and Services Offered
             13.5.3 Recent Developments
             13.5.4 MnM View
     13.6 Covance, Inc.
             13.6.1 Business Overview
             13.6.2 Products and Services Offered
             13.6.3 Recent Developments
     13.7 Janvier Labs
             13.7.1 Business Overview
             13.7.2 Products and Services Offered
             13.7.3 Recent Developments
     13.8 Harbour Antibodies Bv
             13.8.1 Business Overview
             13.8.2 Products Offered
             13.8.3 Recent Developments
     13.9 Transgenic, Inc.
             13.9.1 Business Overview
             13.9.2 Products and Services Offered
             13.9.3 Recent Developments
     13.10 Genoway SA
             13.10.1 Business Overview
             13.10.2 Products and Services Offered
             13.10.3 Recent Developments
     13.11 Sage Labs, Inc. (A Subsidiary of Horizon Discovery Group PLC)
             13.11.1 Business Overview
             13.11.2 Products and Services Offered
             13.11.3 Recent Developments
     13.12 Ingenious Targeting Laboratory
             13.12.1 Business Overview
             13.12.2 Products and Services Offered
             13.12.3 Recent Developments

14 Appendix (Page No. - 231)
     14.1 Discussion Guide
     14.2 Company Developments (2012-2015)
             14.2.1 Charles River Laboratories International, Inc.
             14.2.2 The Jackson Laboratory (JAX)
             14.2.3 Taconic Biosciences Inc.
             14.2.4 Envigo
             14.2.5 Covance, Inc.
             14.2.6 Transgenic, Inc.
             14.2.7 Genoway SA
             14.2.8 Sage Labs, Inc.
     14.3 Introducing RT: Real-Time Market Intelligence
     14.4 Available Customizations
     14.5 Related Reports


List of Tables (119 Tables)

Table 1 Ongoing Innovations in Mice Models are Propelling the Growth of Global Market
Table 2 Increased Usage of Rat Models is Limiting the Adoption of Mice Models in Research
Table 3 Increase in Monoclonal Antibody Production Using Mice Models has A Huge Potential for the Market
Table 4 Need for Improved Mice Models is A Major Market Challenge
Table 5 Market Size, By Type, 2013–2020 (USD Million)
Table 6 Inbred Market Size, By Country, 2013–2020 (USD Million)
Table 7 Outbred Market Size, By Country, 2013–2020 (USD Million)
Table 8 Genetically Engineered Market Size, By Country, 2013–2020 (USD Million)
Table 9 Hybrid/Congenic Market Size, By Country, 2013–2020 (USD Million)
Table 10 Conditioned/Surgically Modified Market Size, By Country, 2013–2020 (USD Million)
Table 11 Spontaneous Mutant Market Size, By Country, 2013–2020 (USD Million)
Table 12 Market Size, By Technology, 2013–2020 (USD Million)
Table 13 Microinjection Market Size, By Country, 2013–2020 (USD Million)
Table 14 Embryonic Stem Cell Injection Market Size, By Country, 2013–2020 (USD Million)
Table 15 Nuclear Transferase Market Size, By Country, 2013–2020 (USD Thousand)
Table 16 Other Mice Model Technologies Market Size, By Country, 2013–2020 (USD Thousand)
Table 17 Global Market, By Service, 2013–2020 (USD Million)
Table 18 Market Size for Breeding Services, By Country, 2013–2020 (USD Million)
Table 19 Market Size for Cryopreservation Services, By Country, 2013–2020 (USD Million)
Table 20 Market Size for Quarantine Services, By Country, 2013–2020 (USD Million)
Table 21 Market Size for Rederivation Services, By Country, 2013–2020 (USD Million)
Table 22 Market Size for Model In-Licensing Services, By Country, 2013–2020 (USD Million)
Table 23 Market Size for Genetic Testing Services, By Country, 2013–2020 (USD Million)
Table 24 Market Size for Other Services, By Country, 2013–2020 (USD Million)
Table 25 Global Market, By Disease, 2013–2020 (USD Million)
Table 26 Recent Cancer Research Studies Using Mice Models
Table 27 Oncology Mice Model Market Size, By Country, 2013–2020 (USD Million)
Table 28 Market for Immunology and Inflammation Studies, By Country, 2013–2020 (USD Million)
Table 29 Market for Diabetes Studies, By Country, 2013–2020 (USD Million)
Table 30 Market for Cardiovascular Studies, By Country, 2013–2020 (USD Million)
Table 31 Recent CNS Disorder-Related Research Studies Using Mice Models
Table 32 Market for Central Nervous System Studies, By Country, 2013–2020 (USD Million)
Table 33 Market for Metabolism and Regulation Studies, By Country, 2013–2020 (USD Million)
Table 34 Market for Other Disease Studies, By Country, 2013–2020 (USD Million)
Table 35 Global Mice Care Products Market Size, By Type, 2013–2020 (USD Million)
Table 36 Mice Care Products Market Size for Cages, By Region, 2013–2020 (USD Thousand)
Table 37 Mice Care Products Market Size for Feed, By Region, 2013–2020 (USD Thousand)
Table 38 Mice Care Products Market Size for Bedding, By Region, 2013–2020 (USD Thousand)
Table 39 Other Mice Care Products Market Size, By Region, 2013–2020 (USD Thousand)
Table 40 Market Size, By Region, 2013–2020 (USD Million)
Table 41 North America: Market Size, By Country, 2013–2020 (USD Million)
Table 42 North America: Market Size, By Type, 2013–2020 (USD Million)
Table 43 North America: Market Size, By Technology, 2013–2020 (USD Million)
Table 44 North America: Market Size, By Service, 2013–2020 (USD Million)
Table 45 North America: Market Size, By Disease, 2013–2020 (USD Million)
Table 46 North America: Mice Care Products, By Type, 2013–2020 (USD Million)
Table 47 Nih Funding for Projects Related to Animal Models
Table 48 Associations Directly Related to the Animal Model Market
Table 49 Associations Indirectly Related to the Animal Model Market
Table 50 U.S.: Market Size, By Type, 2013–2020 (USD Million)
Table 51 U.S.: Market Size, By Technology, 2013–2020 (USD Million)
Table 52 U.S.: Market Size, By Service, 2013–2020 (USD Million)
Table 53 U.S.: Market Size, By Disease, 2013–2020 (USD Million)
Table 54 Canada: Market Size, By Type, 2013–2020 (USD Million)
Table 55 Canada: Market Size, By Technology, 2013–2020 (USD Million)
Table 56 Canada: Market Size, By Service, 2013–2020 (USD Million)
Table 57 Canada: Market Size, By Disease, 2013–2020 (USD Million)
Table 58 Europe: Market Size, By Country, 2013–2020 (USD Million)
Table 59 Europe: Market Size, By Type, 2013–2020 (USD Million)
Table 60 Europe: Market Size, By Technology, 2013–2020 (USD Million)
Table 61 Europe: Market Size, By Service, 2013–2020 (USD Million)
Table 62 Europe: Market Size, By Disease, 2013–2020 (USD Million)
Table 63 Europe: Mice Care Products, By Type, 2013–2020 (USD Thousand)
Table 64 Germany: Market Size, By Type, 2013–2020 (USD Million)
Table 65 Germany: Market Size, By Technology, 2013–2020 (USD Million)
Table 66 Germany: Market Size, By Service, 2013–2020 (USD Million)
Table 67 Germany: Market Size, By Disease, 2013–2020 (USD Million)
Table 68 U.K.: Market Size, By Type, 2013–2020 (USD Million)
Table 69 U.K.: Market Size, By Technology, 2013–2020 (USD Million)
Table 70 U.K.: Market Size, By Service, 2013–2020 (USD Million)
Table 71 U.K.: Market Size, By Disease, 2013–2020 (USD Million)
Table 72 France: Market Size, By Type, 2013–2020 (USD Million)
Table 73 France: Market Size, By Technology, 2013–2020 (USD Thousand)
Table 74 France: Market Size, By Service, 2013–2020 (USD Million)
Table 75 France: Market Size, By Disease, 2013–2020 (USD Million)
Table 76 Stages of Pharma 2020 Strategy
Table 77 European Animal Care Associations and Their Events
Table 78 RoE: Mice Model Market Size, By Type, 2013–2020 (USD Million)
Table 79 RoE: Mice Model Market Size, By Technology, 2013–2020 (USD Million)
Table 80 RoE: Mice Model Market Size, By Service, 2013–2020 (USD Million)
Table 81 RoE: Mice Model Market Size, By Disease, 2013–2020 (USD Million)
Table 82 Asia-Pacific: Mice Model Market Size, By Country, 2013–2020 (USD Million)
Table 83 Asia-Pacific: Mice Model Market Size, By Type, 2013–2020 (USD Million)
Table 84 Asia-Pacific: Mice Model Market Size, By Technology, 2013–2020 (USD Thousand)
Table 85 Asia-Pacific: Mice Model Market Size, By Service, 2013–2020 (USD Million)
Table 86 Asia-Pacific: Mice Model Market Size, By Disease, 2013–2020 (USD Million)
Table 87 Asia-Pacific: Mice Care Products, By Type, 2013–2020 (USD Thousand)
Table 88 China: Mice Model Market Size, By Type, 2013–2020 (USD Million)
Table 89 China: Mice Model Market Size, By Technology, 2013–2020 (USD Thousand)
Table 90 China: Mice Model Market Size, By Service, 2013–2020 (USD Thousand)
Table 91 China: Mice Model Market Size, By Disease, 2013–2020 (USD Million)
Table 92 Japan: Significant Partnerships
Table 93 Japan: Mice Model Market Size, By Type, 2013–2020 (USD Million)
Table 94 Japan: Mice Model Market Size, By Technology, 2013–2020 (USD Thousand)
Table 95 Japan: Mice Model Market Size, By Service, 2013–2020 (USD Thousand)
Table 96 Japan: Mice Model Market Size, By Disease, 2013–2020 (USD Million)
Table 97 Study Results Regarding R&D Expenditure of 25 Pharmaceutical Companies
Table 98 India: Mice Model Market Size, By Type, 2013–2020 (USD Million)
Table 99 India: Mice Model Market Size, By Technology, 2013–2020 (USD Thousand)
Table 100 India: Mice Model Market Size, By Service, 2013–2020 (USD Thousand)
Table 101 India: Mice Model Market Size, By Disease, 2013–2020 (USD Million)
Table 102 RoAPAC: Player Activity, 2013 to 2015
Table 103 Rest of Apac: Mice Model Market Size, By Type, 2013–2020 (USD Million)
Table 104 Rest of Apac: Mice Model Market Size, By Technology, 2013–2020 (USD Thousand)
Table 105 Rest of Apac: Mice Model Market Size, By Service, 2013–2020 (USD Thousand)
Table 106 Rest of Apac: Mice Model Market Size, By Disease, 2013–2020 (USD Million)
Table 107 RoW: Mice Model Market Size, By Type, 2013–2020 (USD Thousand)
Table 108 RoW: Mice Model Market Size, By Technology, 2013–2020 (USD Thousand)
Table 109 RoW: Mice Model Market Size, By Service, 2013–2020 (USD Thousand)
Table 110 RoW: Mice Model Market Size, By Disease, 2013–2020 (USD Thousand)
Table 111 RoW: Mice Care Products, By Type, 2013–2020 (USD Thousand)
Table 112 Collaborations, Agreements, Strategic Alliances, Joint Ventures, and Partnerships (2012–2015)
Table 113 Grants & Funds, 2012–2015
Table 114 Licensing (2012–2015)
Table 115 New Product Launches (2012–2015)
Table 116 Key Players Focusing on Expansions (2012–2015)
Table 117 Patents (2012–2015)
Table 118 Acquisitions (2012–2015)
Table 119 Key Players Focusing on Other Strategies (2012–2015)


List of Figures (47 Figures)

Figure 1 Global Mice Model Market: Research Methodology Steps
Figure 2 Sampling Frame: Primary Research
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market Size Estimation Methodology: Bottom-Up Approach
Figure 5 Market Size Estimation Methodology: Top-Down Approach
Figure 6 Research Design
Figure 7 Data Triangulation Methodology
Figure 8 North America Dominates the Global Mice Model Market
Figure 9 Cryopreservation Services Market to Grow at the Highest CAGR From 2015 to 2020
Figure 10 Asia-Pacific is Expected to Grow at the Highest Rate During the Forecast Period
Figure 11 Ongoing Innovations in Mice Models to Spur Market Growth During the Forecast Period
Figure 12 North America Dominated the Mice Care Products Market in 2015
Figure 13 Asia-Pacific Market to Witness the Highest Growth Rate During the Forecast Period
Figure 14 Microinjection Technology Commanded the Largest Share in 2015
Figure 15 Global Mice Model Market Segmentation
Figure 16 Drivers, Restraints, Opportunities, and Challenges
Figure 17 Genetically Engineered Mice to Be the Fastest Growing Segment
Figure 18 Microinjection Technology Commanded the Largest Share of Mice Model Market in 2015
Figure 19 Mice Model Market, By Service
Figure 20 Breeding Services Accounted for the Largest Share of the Mice Model Market in 2015
Figure 21 Mice Model Market, By Disease
Figure 22 Oncology Mice Models to Dominate the Mice Model Market in 2015
Figure 23 Mice Care Products Market, By Type
Figure 24 Cages Accounted for the Largest Share of the Mice Care Products Market in 2015
Figure 25 Asia-Pacific to Grow at the Highest CAGR in the Mice Model Market During the Forecast Period
Figure 26 The U.S. Commanded the Largest Share in the Mice Model Market in North America in 2015
Figure 27 Germany Dominated the European Mice Model Market in 2015
Figure 28 Number of Cell Therapy Preclinical Studies Listed in the Preclinical Research Database in the U.K., 2013-2015
Figure 29 China: the Fastest Growing Country in the Asia-Pacific Mice Model Market
Figure 30 China Pharma Partnering Activity By Stage – 2009-2014
Figure 31 Oncology Mice Models to Dominate the RoW Mice Models Market, By Diseases
Figure 32 Major Players Focused on Inorganic Growth Strategies
Figure 33 Mice Model Market Share, By Key Player, 2014
Figure 34 Battle for Market Share: Major Collaborations, Agreements, Strategic Alliances, Joint Ventures, and Partnerships Formed the Key Strategy (2012-2015)
Figure 35 Key Players Focusing on Collaborations, Agreements, Strategic Alliances, Joint Ventures, and Partnerships (2012–2015)
Figure 36 Key Players Focusing on Grants & Funds (2012-2015)
Figure 37 Key Players Focusing on Licensing (2012-2015)
Figure 38 Key Players Focusing on New Product Launches (2012-2015)
Figure 39 Key Players Focusing on Expansions (2012-2015)
Figure 40 Key Players Focusing on Patents (2012-2015)
Figure 41 Key Players Focusing on Acquisitions (2012-2015)
Figure 42 Key Players Focusing on Other Strategies (2012-2015)
Figure 43 Business Focus of Top Market Players
Figure 44 Charles River Laboratories International, Inc.: Company Snapshot
Figure 45 The Jackson Laboratory: Company Snapshot
Figure 46 Covance, Inc.: Company Snapshot
Figure 47 Genoway SA: Company Snapshot

The global mice model market is segmented on the basis of type, technology, disease, service and mice care products. By type, the market is categorized into inbred mice, genetically modified mice (knockout, knock-in), conditioned/surgically modified mice, hybrid/congenic mice, outbred mice, and spontaneous mutant mice. The inbred mice are estimated to account for the largest share of the global market, by type. However, knockout mice model are expected to be the fastest-growing market segment owing to high investments in the development of new and innovative knockout models that also increases the application areas for the models.

On the basis of technology, the market is segmented into microinjection, embryonic stem cell injection, nuclear transferase, and other technologies. Other technologies include genetically modified sperm-mediated gene transfer, virus/vector mediated gene transfer, liposome-mediated DNA & electroporation of DNA, biolistics, and CRISPR/Cas9, TALENs & ZFN. In 2015, microinjection technology is expected to command the largest share of the global market, by technology.

The mice model market has been further segmented by disease, which includes oncology, immunology & inflammation-related diseases, diabetes, cardiovascular diseases, central nervous system-related diseases, metabolism & regulation-related diseases, and other diseases. Other diseases include rare diseases and renal disorders. In 2015, the oncology segment is expected to command the largest share of the global market, by disease.

The mice model market, by service, has been segmented into breeding, quarantine, rederivation, cryopreservation, genetic testing, model in-licensing, and other services. Other services include surgical, line rescue, and in vivo pharmacology services. In 2015, breeding services are expected to command the largest share of the global market, by services.

The market also covers the mice care products market, by type, which includes bedding, cages, feed, and other products (gnotobiotic equipment, water systems, and accessories like washing systems, logistics, water purification systems, sound absorption panels). In 2015, cages command the largest share of the global mice care products market.

Ongoing innovations in mice model, personalized medicine fuelling the demand for personalized humanized mice model, continuous support in the form of investments and grants, and increase in R&D activities of pharmaceutical industries are some of the factors that are expected to drive the growth of the global market in the coming years. On the other hand, factors like advancements in genetic techniques for the development of genetically modified rats have led to the increased usage of rat models, thereby restraining the market to some extent. In addition, advances in zebrafish model development, increased benefits from cryopreservation, regulations & laws for the ethical use of animals, and alternative methods to animal testing are some factors expected to restrain the growth of the market. Moreover, the continuous need for improved mice model is posing as a major challenge for the global market.

On the basis of region, this market is categorized into North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

Mice Model Market

Source: International Mouse Phenotyping Consortium (IMPC), The Association of Assessment and Accreditation of Laboratory Animal Care (AAALAC) International, American Association for Laboratory Animal Science (AALAS), International Rare Diseases Research Consortium (IRDiRC), European Society for Alternatives to Animal Testing (ESAAT), European Molecular Biology Laboratory - European Bioinformatics Institute (EMBL-EBI), Swiss Laboratory Animal Science Association, Federation of Laboratory Animal Science Association, The Netherlands Cancer Institute (NKI), U.K. Medical Research Council (MRC), Asian Mouse Mutagenesis Resource Association, Americans for Medical Progress, American Cancer Society, The Japan Society for the Promotion of Science, Tokyo Biochemical Research Expert Interviews, and MarketsandMarkets Analysis
Note: The size of the bubble chart depicts the market size (USD billion) in 2015.

The mice model market is expected to reach USD 1.49 Billion in 2020 from USD 1.05 Billion in 2015, growing at a CAGR of 7.1%. The market is expected to be dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Asia-Pacific is expected to grow at the highest rate during the forecast period.

Charles River Laboratories International, Inc. (U.S.), The Jackson Laboratory (U.S.), Taconic Biosciences, Inc. (U.S.), Envigo (U.K.), Covance, Inc. (U.S.), Janvier Labs France), Harbour Antibodies BV (Netherlands), Transgenic, Inc. (Japan), genOway SA (France), and SAGE Labs, Inc. (U.S.) are some of the key players in the mice model market worldwide.

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo Now